The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VAXX FINANCIAL STATEMENTS

Vaxxinity Inc — balance sheet, income statement and cash flow trends

VAXXVaxxinity Inc

🇺🇸 USA · PINK · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M-50 M020202021202220232024

Profit Funnel

Q1 2024 · TTM
Revenue0 $Gross Profit-2.1 M $ · -Infinity%Operating Income-51.2 M $ · -Infinity%Pre-tax Income-49.9 M $ · -Infinity%Net Income to Owners-49.9 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit-2.1 M $—
Operating Income-51.2 M $—
EBITDA-47.6 M $—
Net Income to Owners-49.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M20202021202220232024

Capital Structure

Q1 2024
Total Assets44.3 M
  • Equity13.4 M $30%
  • Current Liabilities17.6 M $40%
  • Long-term Liabilities13.3 M $30%

Key Figures

YoY change
Total Assets44.3 M $-48.2%
Total Liabilities30.9 M $-21.6%
Total Equity13.4 M $-70.9%
Cash & ST Investments30.4 M $-55.0%
Total Debt15.2 M $+8.5%
Net Debt10.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-75 M-50 M-25 M020202021202220232024

Cash Flow Bridge

Q1 2024 · TTM
-40 M-20 M0-49 M $Operating19.7 M $Investing-879 K $Financing-30.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-49 M $—
Capital Expenditures1 M $-21.1%
Free Cash Flow-50.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VAXX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 1, 26. This content is for informational purposes only and is not investment advice.